NCT02051062View on ClinicalTrials.gov

BT-011 Pharmacokinetics of Botulism Antitoxin Heptavalent in Pediatric Patients

PHASE4Enrolling by invitationINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

July 31, 2027

Study Completion Date

July 31, 2027

Conditions

Botulism

Interventions

BIOLOGICAL

Blood sample collection

One to three 5 mL blood samples will be collected from pediatric participants treated with BAT product ideally 6-24 hours after administration but within a maximum of 32 hours after administration.